Stockreport

Syros Announces Strategic Priorities and Expected Milestones

SYROS PHARMACEUTICALS INC  (SYRS) 
Last syros pharmaceuticals inc earnings: 3/5 06:57 am Check Earnings Report
US:NASDAQ Investor Relations: ir.syros.com
PDF Potential Proof-of-Concept Data for SY-1425 in Combination with Azacitidine in RARA-Positive Relapsed or Refractory AML Patients Expected in Fourth Quarter of 2020Mature [Read more]